Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer

NCT00717951 is registered in ClinicalTrials.gov with Academy Military Medical Science, China as lead sponsor.

NCT NCT00717951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00717951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer
Lead sponsor
Academy Military Medical Science, China
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2008
Completion date
May 31, 2010
Enrollment
120 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced breast cancer